February 2023
Volume 77 | Number 1
Content
IBD
Two years of the COVID-19 pandemic in the population of Czech patients with inflammatory bowel disease treated with biological therapy – experience of the tertiary IBD center
Original articleGastroent Hepatol 2023; 77(1): 14–20. doi: 10.48095/ccgh202314
SummaryLiteraturepdf Karin Černá , Milan LukášPrimary signet ring cell adenocarcinoma as a rare cause of colonic stenosis in a young patient with Crohn’s disease – the case report
Case reportGastroent Hepatol 2023; 77(1): 21–25. doi: 10.48095/ccgh202321
SummaryLiteraturepdf Barbora Pipek, Kateřina Prokešová, Rostislav Kotásek, Michal Štěpán, Petr FojtíkBiological therapy of ulcerative colitis during pregnancy
Case reportGastroent Hepatol 2023; 77(1): 26–29. doi: 10.48095/ccgh202326
SummaryLiteraturepdf Jana KoželuhováComplicated course of IBD in pregnancy
Case reportGastroent Hepatol 2023; 77(1): 30–33. doi: 10.48095/ccgh202330
SummaryLiteraturepdf Václav Štěpánek, Zuzana Šerclová, Mojmír Kasalický, Martin BortlíkOn the question of the interchangeability of monoclonal biosimilar antibodies in the treatment of immune-mediated inflammatory diseases
CommentGastroent Hepatol 2023; 77(1): 34–37. doi: 10.48095/ccgh202334
Literaturepdf Milan Lukáš, Ladislav Šenolt, Spyridon GkalpakiotisClinical and experimental gastroenterology
Gastrointestinal dysfunctions and their influence on the quality of life in aging adults with spinal cord injury
Original articleGastroent Hepatol 2023; 77(1): 38–42. doi: 10.48095/ccgh202338
SummaryLiteraturepdf Jarmila Štěpánová, Petr Pliska, Kateřina RaisováEpidemiological and demographic characteristics of individuals with irritable bowel syndrome based on the Rome III vs. Rome IV criteria in the Northern part of Serbia
Original articleGastroent Hepatol 2023; 77(1): 43–51. doi: 10.48095/ccgh202343
SummaryLiteraturepdf Dusan Slankamenac, Darko Dabic, Aleksandra Dabic, Tamara Slankamenac, Andrej PrevedenAutoimmune hepatitis after vaccination against COVID-19
Case reportGastroent Hepatol 2023; 77(1): 52–56. doi: 10.48095/ccgh202352
SummaryLiteraturepdf Veronika Pítová, Jan Šperl, Pavel Taimr, Ondřej Fabián, Tomáš Miřejovský, Libor Janoušek, Jaroslav Chlupáč, Julius Špičák, Soňa FraňkováThe selection from international journals
CommentsGastroent Hepatol 2023; 77(1): 57–58.
pdf Irena Míková, Kristýna Kaštylová, Vincent Zoundjiekpon, Silvia Cveková17th educational and discussion gastroenterology days
Congress reportGastroent Hepatol 2023; 77(1): 61–62.
pdf Ondřej UrbanTherapeutic monitoring of biologics: on the way to personalized medicine
Congress reportGastroent Hepatol 2023; 77(1): 64–65.
pdf Karin ČernáProfessor Ryska has passed away, his legacy remains
PersonaliaGastroent Hepatol 2023; 77(1): 66.
pdfTofacitinib – is it time for a change in treatment in ulcerative colitis?
AktualitaGastroent Hepatol 2023; 77(1): 78–81.
pdf Kateřina Michnová